Syngoi Technologies attends Europeans summit specialising in mRNA processing and manufacturing market.
April 24, 2023. Frankfurt.
On 18, 19 and 20 April, the first European mRNA Process Development and Manufacturing Summit 2023 was held in Frankfurt.
The aim of the event is built on the vision of the biopharmaceutical industry, this conference is the only forum in Europe that brings together KOLs to delve into the critical challenges associated with mRNA manufacturing. It seeks to explore the future of manufacturing scalable mRNA therapeutics and vaccines from the laboratory to the patient’s bedside and using emerging tools and technologies.
Among the 16+ pioneering speakers from large pharma, innovative biotech, and key academics from companies such as CureVac, BioNTech SE, AstraZeneca, Genentech, Roche, was also Julen Oyarzabal. The CSO and Founder of Syngoi gave an interesting talk on optimised linear synthetic DNA as GMP starting material to improve mRNA production and delivery times. Syngoi Technologies also participated as an official partner of the meeting.
